• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者对SARS-CoV-2疫苗的体液反应与营养状况相关。

The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status.

作者信息

Jacobson-Naftali Merav, Azoulay Odile, Frishman Sigal, Godny Lihi, Zingerman Boris, Rozen-Zvi Benaya, Agur Timna

机构信息

Nephrology & Hypertension Department, Rabin Medical Center, Petaḥ Tikva 4941492, Israel.

Nutrition Unit, Nephrology & Hypertension Department, Rabin Medical Center, Petaḥ Tikva 4941492, Israel.

出版信息

Vaccines (Basel). 2023 Jun 24;11(7):1141. doi: 10.3390/vaccines11071141.

DOI:10.3390/vaccines11071141
PMID:37514958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10386095/
Abstract

Hemodialysis patients are highly susceptible to poor nutritional status. Our objective was to investigate whether poor nutritional status during mRNA-SARS-CoV-2 vaccination is correlated with impaired vaccine responses. This retrospective study was conducted in two hospital-based dialysis units. The nutritional status of hemodialysis patients was assessed, using a malnutrition inflammation score (MIS) at the time of their first BNT162b2 vaccine dose. One month after the second vaccine dose, we performed a quantitative assessment of antibodies against the spike protein (anti-S1 IgG). A total of 115 hemodialysis patients, with an average age of 72 were enrolled in the study. Among them, 39 (33.9%) were female, and 67 (58.2%) had diabetes mellitus. In 43/115 (37.4%) patients, moderate to severe malnutrition (MIS > 5) was detected. Comparatively, malnourished patients showed a lower log-transformed mean level of anti-S1 IgG compared to those with normal nutrition (2.91 ± 0.83 vs. 3.25 ± 0.72, respectively, = 0.024). In a multivariable analysis that adjusted for age, sex, and KT/V, the nutritional status assessed by an MIS remained inversely associated with an anti-S1 IgG response [B; -0.066 (-0.117 to -0.015)]. In conclusion, moderate to severe malnutrition in hemodialysis patients is associated with reduced humoral responses to BNT162b2 vaccination.

摘要

血液透析患者极易出现营养状况不佳的情况。我们的目的是调查mRNA-SARS-CoV-2疫苗接种期间营养状况不佳是否与疫苗反应受损相关。这项回顾性研究在两个医院的透析科室进行。在首次接种BNT162b2疫苗时,使用营养不良炎症评分(MIS)对血液透析患者的营养状况进行评估。在第二次接种疫苗一个月后,我们对针对刺突蛋白的抗体(抗S1 IgG)进行了定量评估。共有115名平均年龄为72岁的血液透析患者纳入研究。其中,39名(33.9%)为女性,67名(58.2%)患有糖尿病。在43/115(37.4%)名患者中,检测到中度至重度营养不良(MIS>5)。相比之下,营养不良患者的抗S1 IgG对数转换平均水平低于营养正常的患者(分别为2.91±0.83和3.25±0.72,P = 0.024)。在一项对年龄、性别和KT/V进行校正的多变量分析中,通过MIS评估的营养状况仍然与抗S1 IgG反应呈负相关[B;-0.066(-0.117至-0.015)]。总之,血液透析患者的中度至重度营养不良与BNT162b2疫苗接种后的体液反应降低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/875fd9a42774/vaccines-11-01141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/462d452cd254/vaccines-11-01141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/86ab23096aa5/vaccines-11-01141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/875fd9a42774/vaccines-11-01141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/462d452cd254/vaccines-11-01141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/86ab23096aa5/vaccines-11-01141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e8f/10386095/875fd9a42774/vaccines-11-01141-g003.jpg

相似文献

1
The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status.血液透析患者对SARS-CoV-2疫苗的体液反应与营养状况相关。
Vaccines (Basel). 2023 Jun 24;11(7):1141. doi: 10.3390/vaccines11071141.
2
Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis.营养不良与血液透析患者对 SARS-CoV-2 疫苗反应的相关性。
Clin Nutr. 2022 Dec;41(12):2683-2690. doi: 10.1016/j.clnu.2022.10.011. Epub 2022 Oct 19.
3
Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients.BNT162b2疫苗接种后六个月透析患者体液反应的持久性
Front Med (Lausanne). 2022 Mar 25;9:781888. doi: 10.3389/fmed.2022.781888. eCollection 2022.
4
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.维持性血液透析或腹膜透析患者接种第三剂 BNT162b2 疫苗后的 SARS-CoV-2 抗体反应。
Am J Kidney Dis. 2022 Feb;79(2):185-192.e1. doi: 10.1053/j.ajkd.2021.08.005. Epub 2021 Sep 8.
5
Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.评估接受血液透析患者对 BNT162b2 疫苗的 SARS-CoV-2 抗体反应。
JAMA Netw Open. 2021 Sep 1;4(9):e2123622. doi: 10.1001/jamanetworkopen.2021.23622.
6
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.mRNA-1273 新冠病毒疫苗在血液透析患者中的安全性和免疫原性。
Front Immunol. 2021 Jun 16;12:704773. doi: 10.3389/fimmu.2021.704773. eCollection 2021.
7
Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.血液透析患者接种三剂 mRNA-BNT162b2 和腺病毒载体 Ad26COVS1 异源 SARS-CoV-2 疫苗后的体液和细胞免疫应答。
Front Immunol. 2022 Jun 23;13:907615. doi: 10.3389/fimmu.2022.907615. eCollection 2022.
8
Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.日本血液透析患者接受第二剂 BNT162b2 mRNA COVID-19 疫苗后与抗 SARS-CoV-2 刺突抗体滴度相关的因素。
Clin Exp Nephrol. 2022 Sep;26(9):925-932. doi: 10.1007/s10157-022-02223-y. Epub 2022 Apr 15.
9
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
10
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis.血液透析患者对 BNT162b2 COVID-19 疫苗第四剂的体液免疫应答减弱。
Clin Exp Nephrol. 2023 Jul;27(7):639-647. doi: 10.1007/s10157-023-02342-0. Epub 2023 Mar 28.

引用本文的文献

1
Chronic heart failure and hypoalbuminemia are risk factors of poorer mRNA SARS-CoV-2 vaccine response in maintenance Hemodialysis patients (the COVaccinDia study).慢性心力衰竭和低白蛋白血症是维持性血液透析患者中mRNA SARS-CoV-2疫苗反应较差的危险因素(COVaccinDia研究)。
BMC Nephrol. 2025 Jun 23;26(1):290. doi: 10.1186/s12882-025-04264-3.

本文引用的文献

1
The Obesity Paradox and Mortality in Older Adults: A Systematic Review.老年人肥胖悖论与死亡率:系统评价。
Nutrients. 2023 Apr 6;15(7):1780. doi: 10.3390/nu15071780.
2
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV.HIV感染者接种SARS-CoV-2 mRNA疫苗后的B细胞反应。
Commun Med (Lond). 2023 Jan 30;3(1):13. doi: 10.1038/s43856-023-00245-5.
3
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations.在体弱人群中接种mRNA疫苗BNT162b2后的体液和T细胞介导反应。
Vaccine X. 2022 Dec;12:100246. doi: 10.1016/j.jvacx.2022.100246. Epub 2022 Dec 5.
4
Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis.营养不良与血液透析患者对 SARS-CoV-2 疫苗反应的相关性。
Clin Nutr. 2022 Dec;41(12):2683-2690. doi: 10.1016/j.clnu.2022.10.011. Epub 2022 Oct 19.
5
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.mRNA SARS-CoV-2 疫苗的第三剂加强了骨髓纤维化患者的刺突特异性抗体和记忆 B 细胞反应。
Front Immunol. 2022 Sep 29;13:1017863. doi: 10.3389/fimmu.2022.1017863. eCollection 2022.
6
Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review.新型冠状病毒肺炎疫苗在糖尿病患者中的免疫原性:系统评价。
Front Immunol. 2022 Aug 29;13:940357. doi: 10.3389/fimmu.2022.940357. eCollection 2022.
7
Vaccination in patients with kidney failure: lessons from COVID-19.肾衰竭患者的疫苗接种:COVID-19 带来的启示。
Nat Rev Nephrol. 2022 Nov;18(11):708-723. doi: 10.1038/s41581-022-00617-5. Epub 2022 Aug 23.
8
Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients.血液透析患者对 BNT162b2 COVID-19 疫苗第三剂的体液反应。
Nephron. 2023;147(3-4):185-192. doi: 10.1159/000525519. Epub 2022 Jul 27.
9
COVID-19 and Nutrition: Summary of Official Recommendations.新型冠状病毒肺炎与营养:官方建议总结
Top Clin Nutr. 2022 Jul-Sep;37(3):187-202. doi: 10.1097/TIN.0000000000000286. Epub 2022 Jun 22.
10
BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients.BNT162b2加强疫苗接种在血液透析患者中诱导针对新冠病毒变异株的免疫力
Vaccines (Basel). 2022 Jun 17;10(6):967. doi: 10.3390/vaccines10060967.